StemCells (STEM) Posts Q1 Results and Data Is Coming, Maxim Group Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
StemCells (STEM) Bullish Stance Reiterated at Maxim Group on Positive Spine Paralysis Data
May 19, 2014 11:57 AM EDTMaxim Group analyst Jason Kolbert reiterated his Buy rating and $2.50 price target on StemCells (NASDAQ: STEM) following positive data on spine paralysis.
Kolbert notes,... More
Stemcells (STEM) Posts Mixed Q1 Results
May 14, 2014 4:02 PM EDTStemcells (NASDAQ: STEM) reported Q1 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $339 thousand versus the consensus estimate of $240 thousand.
For earnings history and earnings-related data on Stemcells (STEM) click here.
... More